Patients With Opioid Use Disorder Deserve Trained Providers
Authors: Melissa B. Weimer, Jeanette M. Tetrault, David A. Fiellin
Journal: Annals of Internal Medicine (2019)

Ideas and Opinions17 December 2019Patients With Opioid Use Disorder Deserve Trained ProvidersMelissa B. Weimer, DO, MCR, Jeanette M. Tetrault, MD, and David A. Fiellin, MDMelissa B. Weimer, DO, MCRYale School of Medicine, New Haven, Connecticut (M.B.W., J.M.T., D.A.F.), Jeanette M. Tetrault, MDYale School of Medicine, New Haven, Connecticut (M.B.W., J.M.T., D.A.F.), and David A. Fiellin, MDYale School of Medicine, New Haven, Connecticut (M.B.W., J.M.T., D.A.F.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M19-2303 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In the midst of a devastating opioid epidemic in the United States, efforts are in motion to deregulate the buprenorphine prescribing process and remove training requirements under the Drug Addiction Treatment Act of 2000 (DATA 2000) that allow providers to prescribe buprenorphine for the treatment of opioid use disorder (OUD) (1–3). Legislation is pending in Congress, and some states and territories have asked the Department of Health and Human Services to take this action. The premise is that buprenorphine is a safe and effective treatment of OUD and that more providers will adopt this relatively "new" practice if the 8-hour ...References1. Fiscella K, Wakeman SE, Beletsky L. Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X waiver. JAMA Psychiatry. 2019;76:229-30. [PMID: 30586140] doi:10.1001/jamapsychiatry.2018.3685 CrossrefMedlineGoogle Scholar2. Haffajee RL, Bohnert ASB, Lagisetty PA. Policy pathways to address provider workforce barriers to buprenorphine treatment. Am J Prev Med. 2018;54:S230-42. [PMID: 29779547] doi:10.1016/j.amepre.2017.12.022 CrossrefMedlineGoogle Scholar3. American Psychiatric Association. Substance use disorder. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Assoc; 2013. Google Scholar4. Netherland J, Botsko M, Egan JE, et al; BHIVES Collaborative. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36:244-51. [PMID: 18715741] doi:10.1016/j.jsat.2008.06.006 CrossrefMedlineGoogle Scholar5. Barry DT, Irwin KS, Jones ES, et al. Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med. 2009;24:218-25. [PMID: 19089500] doi:10.1007/s11606-008-0881-9 CrossrefMedlineGoogle Scholar6. Jones CM, McCance-Katz EF. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Addiction. 2019;114:471-82. [PMID: 30194876] doi:10.1111/add.14436 CrossrefMedlineGoogle Scholar7. Muzyk A, Smothers ZPW, Akrobetu D, et al. Substance use disorder education in medical schools: a scoping review of the literature. Acad Med. 2019. [PMID: 31348067] doi:10.1097/ACM.0000000000002883 CrossrefMedlineGoogle Scholar8. Muzyk A, Smothers ZPW, Andolsek KM, et al. Interprofessional substance use disorder education in health professions education programs: a scoping review. Acad Med. 2019. doi:10.1097/ACM.0000000000003053 CrossrefGoogle Scholar9. Barry DT, Irwin KS, Jones ES, et al. Opioids, chronic pain, and addiction in primary care. J Pain. 2010;11:1442-50. [PMID: 20627817] doi:10.1016/j.jpain.2010.04.002 CrossrefMedlineGoogle Scholar10. Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. [PMID: 28446428] doi:10.1136/bmj.j1550 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Yale School of Medicine, New Haven, Connecticut (M.B.W., J.M.T., D.A.F.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2303.Corresponding Author: Melissa B. Weimer, DO, MCR, Yale School of Medicine, 367 Cedar Street, Suite 417A, New Haven, CT 06510; e-mail, Melissa.[email protected]edu.Current Author Addresses: Dr. Weimer: Yale School of Medicine, 367 Cedar Street, Suite 417A, New Haven, CT 06510.Dr. Tetrault: Yale School of Medicine, 367 Cedar Street, Suite 305, New Haven, CT 06510.Dr. Fiellin: Yale School of Medicine, 367 Cedar Street, New Haven, CT 06510.Author Contributions: Conception and design: M.B. Weimer, J.M. Tetrault, D.A. Fiellin.Drafting of the article: M.B. Weimer, J.M. Tetrault, D.A. Fiellin.Critical revision of the article for important intellectual content: M.B. Weimer, J.M. Tetrault, D.A. Fiellin.Final approval of the article: M.B. Weimer, J.M. Tetrault, D.A. Fiellin.Administrative, technical, or logistic support: M.B. Weimer, J.M. Tetrault, D.A. Fiellin.This article was published at Annals.org on 26 November 2019. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPatients With Opioid Use Disorder Deserve Trained Providers Richard Saitz Patients With Opioid Use Disorder Deserve Trained Providers Justin Berk , J. Deanna Wilson , James H. Miller , and Leonard Feldman Patients With Opioid Use Disorder Deserve Trained Providers Melissa B. Weimer , Jeanette M. Tetrault , and David A. Fiellin Patients With Opioid Use Disorder Deserve Trained Providers Kevin Fiscella , Leo Beletsky , and Sarah E. Wakeman Metrics Cited byEducation as drug policy: A realist synthesis of continuing professional development for opioid agonist therapyConsensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use DisorderA Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)Adapting Palliative Care Skills to Provide Substance Use Disorder Treatment to Patients With Serious IllnessOpioid use disorder and COVID-19Evaluation of Resident Physicians' Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder"Rapid Start" Treatment to End the (Other) Epidemic: Walking the Tightrope Without a NetTraining Medical Students, Residents, and Fellows in Opioid Use Disorder TreatmentPatients With Opioid Use Disorder Deserve Trained ProvidersKevin Fiscella, MD, MPH, Leo Beletsky, JD, MPH, and Sarah E. Wakeman, MDPatients With Opioid Use Disorder Deserve Trained ProvidersRichard Saitz, MD, MPHPatients With Opioid Use Disorder Deserve Trained ProvidersJustin Berk, MD, MPH, MBA, J. Deanna Wilson, MD, MPH, James H. Miller, MD, and Leonard Feldman, MD 17 December 2019Volume 171, Issue 12Page: 931-932KeywordsChild healthComputed axial tomographyGraduate medical educationHealth careHealth care providersMedical educationOpioid addictionOpioid use disorderOpioidsPatients ePublished: 26 November 2019 Issue Published: 17 December 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...